Task: Answer the multiple-choice question.
Query: Which drug exhibits a -22.098% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C
b: Cc1ccc(-c2nn(CCC(=O)O)cc2CCC(=O)O)cc1
c: CCN1CCN(c2ncnc3c2cnn3-c2ccc(Cl)cc2)CC1
Answer: c. CCN1CCN(c2ncnc3c2cnn3-c2ccc(Cl)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2ncnc3c2cnn3-c2ccc(Cl)cc2)CC1
CCN1CCN(c2ncnc3c2cnn3-c2ccc(Cl)cc2)CC1
1-(4-chlorophenyl)-4-(4-ethylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidine